These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 24652914)

  • 1. Impact of 6-month aerobic exercise on Alzheimer's symptoms.
    Yu F; Thomas W; Nelson NW; Bronas UG; Dysken M; Wyman JF
    J Appl Gerontol; 2015 Jun; 34(4):484-500. PubMed ID: 24652914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive Effects of Aerobic Exercise in Alzheimer's Disease: A Pilot Randomized Controlled Trial.
    Yu F; Vock DM; Zhang L; Salisbury D; Nelson NW; Chow LS; Smith G; Barclay TR; Dysken M; Wyman JF
    J Alzheimers Dis; 2021; 80(1):233-244. PubMed ID: 33523004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inter-individual differences in the responses to aerobic exercise in Alzheimer's disease: Findings from the FIT-AD trial.
    Yu F; Salisbury D; Mathiason MA
    J Sport Health Sci; 2021 Jan; 10(1):65-72. PubMed ID: 32505710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of aerobic exercise on cognition and hippocampal volume in Alzheimer's disease: study protocol of a randomized controlled trial (The FIT-AD trial).
    Yu F; Bronas UG; Konety S; Nelson NW; Dysken M; Jack C; Wyman JF; Vock D; Smith G
    Trials; 2014 Oct; 15():394. PubMed ID: 25304364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Change in Fitness and the Relation to Change in Cognition and Neuropsychiatric Symptoms After Aerobic Exercise in Patients with Mild Alzheimer's Disease.
    Sobol NA; Dall CH; Høgh P; Hoffmann K; Frederiksen KS; Vogel A; Siersma V; Waldemar G; Hasselbalch SG; Beyer N
    J Alzheimers Dis; 2018; 65(1):137-145. PubMed ID: 30040719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular biomarkers to predict response to exercise in Alzheimer's disease: the study protocol.
    Li D; Thomas R; Tsai MY; Li L; Vock DM; Greimel S; Yu F
    BMJ Open; 2016 Dec; 6(12):e011054. PubMed ID: 28039287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropsychiatric symptoms in Alzheimer's disease: associations with caregiver burden and treatment outcomes.
    Chen CT; Chang CC; Chang WN; Tsai NW; Huang CC; Chang YT; Wang HC; Kung CT; Su YJ; Lin WC; Cheng BC; Su CM; Hsiao SY; Hsu CW; Lu CH
    QJM; 2017 Sep; 110(9):565-570. PubMed ID: 28383687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropsychiatric Symptoms, Caregiver Burden and Distress in Behavioral-Variant Frontotemporal Dementia and Alzheimer's Disease.
    Lima-Silva TB; Bahia VS; Carvalho VA; Guimarães HC; Caramelli P; Balthazar ML; Damasceno B; Bottino CM; Brucki SM; Nitrini R; Yassuda MS
    Dement Geriatr Cogn Disord; 2015; 40(5-6):268-75. PubMed ID: 26302667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of behavioral and psychological symptoms on caregiver burden in frontotemporal dementia, Lewy body dementia, and Alzheimer's disease: clinical experience in China.
    Liu S; Jin Y; Shi Z; Huo YR; Guan Y; Liu M; Liu S; Ji Y
    Aging Ment Health; 2017 Jun; 21(6):651-657. PubMed ID: 26882509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aerobic and strength training exercise programme for cognitive impairment in people with mild to moderate dementia: the DAPA RCT.
    Lamb SE; Mistry D; Alleyne S; Atherton N; Brown D; Copsey B; Dosanjh S; Finnegan S; Fordham B; Griffiths F; Hennings S; Khan I; Khan K; Lall R; Lyle S; Nichols V; Petrou S; Zeh P; Sheehan B
    Health Technol Assess; 2018 May; 22(28):1-202. PubMed ID: 29848412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive activity for the treatment of older adults with mild Alzheimer's disease (AD)--PACE AD: study protocol for a randomised controlled trial.
    Vidovich MR; Shaw J; Flicker L; Almeida OP
    Trials; 2011 Feb; 12():47. PubMed ID: 21329501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with long-term impact on informal caregivers during Alzheimer's disease dementia progression: 36-month results from GERAS.
    Reed C; Belger M; Scott Andrews J; Tockhorn-Heidenreich A; Jones RW; Wimo A; Dodel R; Haro JM
    Int Psychogeriatr; 2020 Feb; 32(2):267-277. PubMed ID: 31134870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial Effects of an Integrated Psychostimulation Program in Patients with Alzheimer's Disease.
    Ibarria M; Alegret M; Valero S; Morera A; Guitart M; Cañabate P; Moreno M; Lara S; Diego S; Hernández J; Tantinyá N; Vera M; Hernández I; Becker JT; Ruíz A; Boada M; Tárraga L
    J Alzheimers Dis; 2016; 50(2):559-66. PubMed ID: 26757182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the impact of neuropsychiatric symptoms in Alzheimer's disease: the Neuropsychiatric Inventory Caregiver Distress Scale.
    Kaufer DI; Cummings JL; Christine D; Bray T; Castellon S; Masterman D; MacMillan A; Ketchel P; DeKosky ST
    J Am Geriatr Soc; 1998 Feb; 46(2):210-5. PubMed ID: 9475452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carotid intima-media thickness as a predictor of response to cholinesterase inhibitors in Alzheimer's disease: an open-label trial.
    Modrego PJ; Rios C; Pérez Trullen JM; García-Gómara MJ; Errea JM
    CNS Drugs; 2009; 23(3):253-60. PubMed ID: 19320533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Donepezil in Alzheimer's disease: eighteen month results from Southampton Memory Clinic.
    Matthews HP; Korbey J; Wilkinson DG; Rowden J
    Int J Geriatr Psychiatry; 2000 Aug; 15(8):713-20. PubMed ID: 10960883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pilot randomized controlled trial evaluating an integrated treatment of rivastigmine transdermal patch and cognitive stimulation in patients with Alzheimer's disease.
    D'Onofrio G; Sancarlo D; Addante F; Ciccone F; Cascavilla L; Paris F; Elia AC; Nuzzaci C; Picoco M; Greco A; Panza F; Pilotto A
    Int J Geriatr Psychiatry; 2015 Sep; 30(9):965-75. PubMed ID: 25504466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moderate-to-high intensity aerobic exercise in patients with mild to moderate Alzheimer's disease: a pilot study.
    Frederiksen KS; Sobol N; Beyer N; Hasselbalch S; Waldemar G
    Int J Geriatr Psychiatry; 2014 Dec; 29(12):1242-8. PubMed ID: 24733599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Memantine effects measured with the Relevant Outcome Scale for Alzheimer's disease in an open-label, single-arm, multicenter clinical study.
    Holthoff V; Ferris S; Gauthier S; Ihl R; Robert P; Winblad B; Sternberg K; Tennigkeit F;
    Int J Geriatr Psychiatry; 2013 Feb; 28(2):164-72. PubMed ID: 22492589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of the Icelandic version of the Neuropsychiatric Inventory with Caregiver Distress (NPI-D).
    Davidsdottir SR; Snaedal J; Karlsdottir G; Atladottir I; Hannesdottir K
    Nord J Psychiatry; 2012 Feb; 66(1):26-32. PubMed ID: 21770826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.